The Current Ratio as of September 2024 (TTM) for Decibel Therapeutics, Inc. (DBTX) is 3.03

According to Decibel Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.03. This represents a change of -30.33% compared to the average of 4.34 of the last 4 quarters.

Decibel Therapeutics, Inc. (DBTX) Historical Current Ratio (quarterly & annually)

How has DBTX Current Ratio performed in the past?

The mean historical Current Ratio of Decibel Therapeutics, Inc. over the last ten years is 5.39. The current 3.03 Current Ratio has changed 5.52% with respect to the historical average. Over the past ten years (40 quarters), DBTX's Current Ratio was at its highest in in the March 2021 quarter at 12.56. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Decibel Therapeutics, Inc. (DBTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Decibel Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Decibel Therapeutics, Inc. (DBTX) Average Current Ratio

How has DBTX Current Ratio performed in the past?

The current Current Ratio of Decibel Therapeutics, Inc. (DBTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Decibel Therapeutics, Inc. (DBTX) Current Ratio vs. Peers

How is DBTX’s Current Ratio compared to its peers?

Decibel Therapeutics, Inc.’s Current Ratio is less than Werewolf Therapeutics, Inc. (12.13), less than Edgewise Therapeutics, Inc. (30.24), less than Celcuity Inc. (14.95), less than C4 Therapeutics, Inc. (5.09), less than Aerovate Therapeutics, Inc. (6.51), greater than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (16.16), less than Rezolute, Inc. (11.82), less than AN2 Therapeutics, Inc. (10.61), less than Ikena Oncology, Inc. (18.22), less than Eliem Therapeutics, Inc. (60.41), less than Anebulo Pharmaceuticals, Inc. (5.32), greater than HCW Biologics Inc. (0.10), less than Molecular Partners AG (14.58),

Build a custom stock screener for Decibel Therapeutics, Inc. (DBTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Decibel Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Decibel Therapeutics, Inc. (DBTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Decibel Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.